Search
for
Sort by
Research 931–960 of 1000+
- Index
- Effects of vinblastine and its metabolites on nausea and alopecia associated receptors
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Contents
- Contents
- Contents
- Treatment of acne with intermittent isotretinoin, cohort study
- [Skin manifestations in patients with renal chronic renal failure on regular hemodyalysis].
- A IMPORTÂNCIA DA ATENÇÃO FARMACÊUTICA DIANTE DO AUMENTO DA PRESCRIÇÃO E USO INDISCRIMINADO DE ANSIOLÍTICOS COM FOCO NOS BENZODIAZEPÍNICOS E NA PASSIFLORA INCARNATA L.
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Use of topical minoxidil in the treatment of male pattern baldness
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
- Finasteride Treatment of Hair Loss in Women
- A Review of U.S. Patents in the Field of Organic Process Development Published during July and August 2004
- Systematic review of exosome treatment in hair restoration: Preliminary evidence, safety, and future directions
- Three Cases of Hemodialysis Patients with Advanced Gastric Cancer Treated with Paclitaxel and Nab Paclitaxel
- Dermatological drugs, topical agents, and cosmetics
- Gingival Hyperplasia Secondary to Everolimus Therapy
- Drugs affecting blood coagulation, fibrinolysis, and hemostasis
- Philosophy and technique in hair restoration surgery
- Anti-anginal and beta-adrenoceptor blocking drugs
- Gas Chromatography Tandem Mass Spectrometry for Biomarkers of Alcohol Abuse in Human Hair
- Long-term opioid ADR management in cancer patients
- Methotrexate/tacrolimus/voriconazole
- Latanoprost
- Investigating drug induced alopecia
- Synthetic hair reactions and treatment of complications: Case reports
- DRUG‐ASSOCIATED ALOPECIA
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management